AzTrials
AzTrials

Developmental DisabilityNCT03904797

Electronic Patient-reported Outcomes (e-PROs) in Early Intervention

A study testing Young Children's Participation and Environment Measure (YC-PEM) electronic patient-reported outcome (e-PRO) in people with Developmental Disability and Development Delay, run by University of Illinois at Chicago.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A major goal of early intervention (EI) is to employ a family-centered approach to helping children to optimally function at home and in the community. However, the effects of EI are poorly understood. Read more about this study

Who is it for?
Ages 1 month to 36 months
Conditions the study is for
Developmental Disability, Development Delay
What is being tested?
Young Children's Participation and Environment Measure (YC-PEM) electronic patient-reported outcome (e-PRO)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
149 participants
Where
No sites listed yet
Study dates
1 Apr 2016to 1 Feb 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 36 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Caregiver is at least 18 years old;
  • Caregiver can read, write, and speak English or Spanish;
  • Caregiver had internet access;
  • Caregiver has a child between 0-3 years old who had received early intervention at RMHS for at least 3 months.

Who cannot join

  • Caregiver is less than 18 years old
  • Caregiver reads, speaks, and writes in a language other than English or Spanish
  • Caregiver does not have internet access
  • Caregiver has a child who has received EI services for less than 3 months
  • Caregiver has a child older than 3 years (36 months)

About this study

Official title: Colorado Early Intervention Outcomes Research Using Innovative Patient-Reported Outcome (PRO) Measures

A major goal of early intervention (EI) is to employ a family-centered approach to helping children to optimally function at home and in the community. However, the effects of EI are poorly understood. The aims of this project are: 1) to test the feasibility, acceptability, and value of introducing novel electronic patient-reported outcome (e-PRO) measures in EI, to strengthen family-centered EI care; and 2) to obtain and pair these outcomes data with EI program data, to further determine the value of e-PRO data collection for examining links between EI service use and functional outcomes among families who are enrolled in a large, urban EI program.

Read the detailed description

Approximately 5,800 infants and toddlers with developmental disabilities (e.g., cerebral palsy, Down syndrome, complex chronic conditions) and delays access Early Intervention Colorado (EI-CO) annually. A primary goal of EI-CO is to employ a family-centered care approach to help children optimally function at home and in the community. Hence, early intervention is a common source of rehabilitation (i.e., physical, occupational, speech and language therapy) for EI-CO eligible families.

However, the effects of EI-CO are poorly understood. Numerous challenges exist with obtaining EI-CO outcomes data, including a paucity of validated and feasible functional outcome measures for use in EI outcomes reporting. These challenges have resulted in inadequate knowledge about EI service use and outcomes to guide service delivery. Despite these challenges, recent policy changes have resulted in EI-CO service providers being pressed to ensure high quality care with limited resources and evidence to guide their clinical decision-making about effective and efficient interventions. This proposal addresses the need to fill critical knowledge gaps about the adequacy of EI services with an eye toward improving care quality.

This study involves families who have/are receiving EI-CO services through Rocky Mountain Human Services (RMHS), the largest EI program in Denver Metro. The purpose of this study is to test the feasibility, acceptability, and value of collecting electronic patient-reported outcomes (e-PRO) data to engage families when their child is due for an annual evaluation of progress. To further demonstrate the value of e-PRO data collection, these data will be paired with program data to estimate the association between EI-CO service use and functional outcomes.

Being tested
Young Children's Participation and Environment Measure (YC-PEM) electronic patient-reported outcome (e-PRO)
Keywords
patient-reported outcome, electronic, participation, early intervention
Medical subject headings
Developmental Disabilities, Learning Disabilities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Young Children's Participation and Environment Measure (YC-PEM) electronic patient-reported outcome (e-PRO)Behavioural

    Participants were primary caregivers (n=149) recruited from a large, urban early intervention program. All caregivers were approached by early intervention staff the month prior to the child's annual evaluation of progress.

    Each caregiver confirmed his or her eligibility online by verifying that they were at least 18 years old; could read, write, and speak English or Spanish; had internet access; and had a child between 0-3 years old who had received early intervention for at least 3 months.

    Participants enrolled online and provided consent, signed a HIPAA authorization for service record release, and then proceeded to completing a demographic questionnaire and YC-PEM e-PRO to receive an online report of their responses to share with their child's EI team.

Study groups in NCT03904797
Study groupRoleWhat they receive
e-PROExperimentalEI service coordinators participated in a 90-minute training on the study protocol, to gain clearance to recruit families when they were being contacted to schedule their annual reviews of progress. The recruitment protocol was later modified in response to low enrollment, such that a designated EI staff member was paired with research staff to recruit participants. Eligible and interested caregivers visited the project website to create an account, confirmed study eligibility, provided informed consent and HIPAA authorization for abstracting select EI service use data, and completed a demographic questionnaire and the Young Children's Participation and Environment Measure (YC-PEM) e-PRO. Caregivers received immediate access to an online report summarizing their e-PRO responses to share with their child's EI team
Receives: Behavioral: Young Children's Participation and Environment Measure (YC-PEM) electronic patient-reported outcome (e-PRO)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. YC-PEM e-PRO Feasibility as assessed by enrollment rate

    Enrollment rate was estimated as the proportion of eligible participants who enrolled in the study. The success of feasibility was determined as e-PRO enrollment rates of 50% or higher based on what is known about the percentage of families who opt into family assessment as part of usual care.

    Measured: up to 4 weeks

  2. YC-PEM e-PRO Acceptability as assessed by caregiver perceptions of overall helpfulness

    Caregiver responses to an open-ended item were coded into a one of three categories (yes, helpful; somewhat helpful; not helpful) to create a new variable that captured the extent to which caregivers perceived the YC-PEM e-PRO to be useful for planning EI care.

    Measured: up to 4 weeks

  3. YC-PEM e-PRO Value as assessed by proportion of participants viewing e-PRO online report

    The percentage of participants who viewed a summary of their e-PRO responses via an online report was estimated.

    Measured: up to 4 weeks

  4. YC-PEM e-PRO Feasibility as assessed by completion rate

    Feasibility was determined as the proportion of participants who enrolled that completed the YC-PEM e-PRO. The success of feasibility was determined as completion rates of 50% or higher based on family assessment completion rates within usual care.

    Measured: up to 4 weeks

  5. YC-PEM e-PRO Feasibility as assessed by completion time in minutes and seconds

    The success of feasibility was determined as e-PRO completion time of less than 45 minutes based on family assessment completion time within usual care.

    Measured: up to 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2019
  2. Study start1 Apr 2016
  3. Primary completion1 Sep 2018
  4. Study completion1 Feb 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
149 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03904797
Sponsor's protocol ID
2016-0139
Status last verified
Mar 2019
First submitted
25 Mar 2019
Last updated
5 Apr 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: NIH funds were secured to archive a subset of the data as a restricted use data file, and the dataset is being curated now.

Publications

  • Albrecht EC, Kaelin VC, Rigau BL, Dooling-Litfin JK, Scully EA, Murphy NJ, McManus BM, Khetani MA; High Value Early Intervention Research Group. Pilot implementation of an electronic patient-reported outcome measure for planning and monitoring participation-focused care in early intervention. BMC Med Inform Decis Mak. 2020 Aug 24;20(1):199. doi: 10.1186/s12911-020-01189-9.

    PubMed 32838772
  • Khetani MA, McManus BM, Albrecht EC, Kaelin VC, Dooling-Litfin JK, Scully EA; High Value Early Intervention Research Group. Early intervention service intensity and young children's home participation. BMC Pediatr. 2020 Jul 3;20(1):330. doi: 10.1186/s12887-020-02182-x.

    PubMed 32620161

Questions about this trial

What is this clinical trial studying?

A study testing Young Children's Participation and Environment Measure (YC-PEM) electronic patient-reported outcome (e-PRO) in people with Developmental Disability and Development Delay, run by University of Illinois at Chicago.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

YC-PEM e-PRO Feasibility as assessed by enrollment rate (time frame: up to 4 weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03904797, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in